| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
microRNA 146a | 0.398 | 0.885 |
|
disease | 0.100 | None | 0.889 | 36 | 1 | 2008 | 2019 | |||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
disease | 0.100 | None | 1.000 | 29 | 1 | 2008 | 2019 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.100 | None | 1.000 | 27 | 0 | 1994 | 2019 | |||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
disease | 0.100 | None | 1.000 | 25 | 0 | 1994 | 2019 | |||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.100 | None | 0.880 | 25 | 0 | 1989 | 2019 | |||||||||
|
basic transcription factor 3 pseudogene 11 | 0.519 | 0.731 |
|
disease | 0.100 | None | 0.941 | 17 | 0 | 2004 | 2019 | |||||||||
|
Cerebellar degeneration-related autoantigen-3 | 0.472 | 0.808 |
|
disease | 0.100 | None | 0.875 | 16 | 0 | 1992 | 2019 | |||||||||
|
microRNA 223 | 0.433 | 0.808 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 2010 | 2019 | |||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.100 | None | 0.857 | 14 | 0 | 2003 | 2019 | |||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
disease | 0.100 | None | 0.857 | 14 | 0 | 2003 | 2019 | |||||||||
|
neutrophil migration | 0.473 | 0.808 |
|
disease | 0.100 | None | 0.917 | 12 | 0 | 2000 | 2020 | |||||||||
|
immunoglobulin heavy variable 4-38-2-like | 0.514 | 0.769 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 1993 | 2017 | |||||||||
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 | 0.527 | 0.769 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 1993 | 2017 | |||||||||
|
major histocompatibility complex, class II, DR beta 4 | 0.565 | 0.846 |
|
disease | 0.100 | None | 0.800 | 10 | 0 | 1989 | 2019 | |||||||||
|
microRNA 499a | 0.519 | 0.846 |
|
disease | 0.100 | None | 0.900 | 10 | 1 | 2011 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 2605 | 0.490 | 0.769 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2005 | 2018 | |||||||||
|
Wegener granulomatosis | 0.595 | 0.808 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2009 | 2019 | |||||||||
|
Cbl proto-oncogene like 2 | 0.476 | 0.808 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2005 | 2019 | |||||||||
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1 | 0.537 | 0.769 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2006 | 2019 | |||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2014 | 2019 | |||||||||
|
mannose-binding lectin family member 3, pseudogene | 0.518 | 0.769 |
|
disease | 0.070 | None | 0.857 | 7 | 0 | 2000 | 2011 | |||||||||
|
complement component 4B (Chido blood group), copy 2 | 0.670 | 0.731 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1989 | 1992 | |||||||||
|
KLRC4-KLRK1 readthrough | 0.469 | 0.769 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2007 | 2018 | |||||||||
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
disease | 0.100 | None | 1.000 | 6 | 221 | 2007 | 2014 | |||||||||
|
Hashimoto thyroiditis | 0.505 | 0.731 |
|
disease | 0.060 | None | 0.833 | 6 | 0 | 2004 | 2019 |